Wegovy pill sales exceed 500,000 units in UK by 2026-12-31

Private pharmacy sales of the Wegovy weight loss pill in the UK will surpass 500,000 units by the end of 2026, driven by demand for non-injectable semaglutide alternatives. Initial supply constraints and strict prescribing guidelines may limit early uptake, but strong clinician referrals and online pharmacy distribution will accelerate adoption.

adoption · Prediction Market

Implied probability (Yes)

72%

Closes

2026-12-31

More adoption markets

• OpenAI Codex mobile usage exceeds desktop by Q1 2027 — 72% Yes
• OpenAI Codex mobile usage surpasses desktop within 6 months — 70% Yes
• Major tech companies to mandate AI voice tools in offices by 2027 — 70% Yes
• Animal rights NGOs expand operations in Uganda by 2027 — 75% Yes
• Elliott Management opens new China-focused fund within 9 months — 55% Yes
• Decline in assets under management for single-stock leveraged ETFs by 2027-06-30 — 60% Yes
• Canvas adoption declines by 5% among K-12 schools in 2026 — 70% Yes
• Anthropic's enterprise AI share surpasses 30% by Q4 2026 — 75% Yes

Browse all adoption markets →